Publications by authors named "Laura Pike"

15Publications

First-in-Class Inhibitors of Oncogenic CHD1L with Preclinical Activity against Colorectal Cancer.

Mol Cancer Ther 2020 08 4;19(8):1598-1612. Epub 2020 Jun 4.

The Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, The University of Colorado Anschutz Medical Campus, Aurora, Colorado.

View Article and Find Full Text PDF
August 2020

FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes.

Mol Cancer Res 2016 09 3;14(9):869-82. Epub 2016 Jun 3.

Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado. University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, Colorado.

View Article and Find Full Text PDF
September 2016

Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.

Horm Cancer 2015 Jun 24;6(2-3):87-99. Epub 2015 Mar 24.

Department of Medicine, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus, 12801 E. 17th Ave, MS 8106, Aurora, CO, 80045, USA,

View Article and Find Full Text PDF
June 2015

A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer.

Thyroid 2015 May 7;25(5):563-4. Epub 2015 Apr 7.

1 Department of Medicine, Division of Endocrinology, Metabolism, and Diabetes, The University of Colorado School of Medicine , Aurora, Colorado.

View Article and Find Full Text PDF
May 2015

Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer.

Mol Cancer 2014 Mar 19;13:62. Epub 2014 Mar 19.

Department of Medicine, Division of Endocrinology, Diabetes, & Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

View Article and Find Full Text PDF
March 2014

Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis.

Clin Cancer Res 2012 Jul 14;18(13):3580-91. Epub 2012 May 14.

Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado 80045, USA.

View Article and Find Full Text PDF
July 2012

PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells.

PPAR Res 2011 12;2011:171765. Epub 2011 Dec 12.

Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.

View Article and Find Full Text PDF
August 2012